Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Bio-pharma market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.6% during the forecast period.
This report presents the market size and development trends by detailing the Bio-pharma market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Bio-pharma market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Bio-pharma industry and will help you to build a panoramic view of the industrial development.
Bio-pharma Market, By Type:
Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Interferons
Recombinant Human Insulin
Erythropoietin
Vaccines
Growth Hormones
Purified Proteins
Others
Bio-pharma Market, By Application:
Metabolic Disorders
Oncology
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases
Others
Some of the leading players are as follows:
AstraZeneca PLC
AbbVie
Johnson & Johnson Services
Pfizer
Bristol-Myers Squibb Company
Abbott Laboratories
Bayer AG
Novartis AG GlaxoSmithKline Plc
Sanofi, Amgen
Biogen Idec
Eli Lilly and Company
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Bio-pharma Market
-
1.3 Market Segment by Type
-
1.3.1 Monoclonal Antibodies
-
1.3.2 Recombinant Proteins
-
1.3.3 Granulocyte-Colony Stimulating Factor (G-CSF)
-
1.3.4 Interferons
-
1.3.5 Recombinant Human Insulin
-
1.3.6 Erythropoietin
-
1.3.7 Vaccines
-
1.3.8 Growth Hormones
-
1.3.9 Purified Proteins
-
1.3.10 Others
-
1.4 Market Segment by Application
-
1.4.1 Metabolic Disorders
-
1.4.2 Oncology
-
1.4.3 Neurological Disorders
-
1.4.4 Cardiovascular Diseases
-
1.4.5 Inflammatory and Infectious Diseases
-
1.4.6 Others
-
1.5 Market Segment by Regions
-
1.5.1 North America Bio-pharma Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Europe Bio-pharma Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Asia-Pacific Bio-pharma Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 LAMEA Bio-pharma Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Bio-pharma Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Bio-pharma by Major Types
-
3.4.1 Monoclonal Antibodies
-
3.4.2 Recombinant Proteins
-
3.4.3 Granulocyte-Colony Stimulating Factor (G-CSF)
-
3.4.4 Interferons
-
3.4.5 Recombinant Human Insulin
-
3.4.6 Erythropoietin
-
3.4.7 Vaccines
-
3.4.8 Growth Hormones
-
3.4.9 Purified Proteins
-
3.4.10 Others
4 Segmentation of Bio-pharma Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Bio-pharma by Major End-Users
-
4.4.1 Metabolic Disorders
-
4.4.2 Oncology
-
4.4.3 Neurological Disorders
-
4.4.4 Cardiovascular Diseases
-
4.4.5 Inflammatory and Infectious Diseases
-
4.4.6 Others
5 Market Analysis by Major Regions
-
5.1 Global Bio-pharma Production Analysis by Top Regions
-
5.2 Global Bio-pharma Consumption Analysis by Top Regions
-
5.3 Global Bio-pharma Production, Import, Consumption and Export Analysis by Regions
-
5.3.1 North America Bio-pharma Production, Import, Consumption and Export Analysis
-
5.3.2 Europe Bio-pharma Production, Import, Consumption and Export Analysis
-
5.3.3 Asia Pacific Bio-pharma Production, Import, Consumption and Export Analysis
-
5.3.4 LAMEA Bio-pharma Production, Import, Consumption and Export Analysis
6 Product Circulation of Bio-pharma Market among Top Countries
-
6.1 Top 5 Export Countries in Bio-pharma Market from 2014 to 2019
-
6.1.1 Top 5 Export Countries’ Export Value Analysis in Bio-pharma Market from 2014 to 2019
-
6.1.2 Top 5 Export Countries’ Export Volume Analysis in Bio-pharma Market from 2014 to 2019
-
6.2 Top 5 Import Countries in Bio-pharma Market from 2014 to 2019
-
6.2.1 Top 5 Import Countries’ Import Value Analysis in Bio-pharma Market from 2014 to 2019
-
6.2.2 Top 5 Import Countries’ Import Volume Analysis in Bio-pharma Market from 2014 to 2019
-
6.3 Emerging Top 3 Export Countries Analysis
-
6.4 Emerging Top 3 Import Countries Analysis
7. North America Bio-pharma Landscape Analysis
-
7.1 North America Bio-pharma Landscape Analysis by Top Countries
-
7.1.1 United States Bio-pharma Market Volume and Growth Rate
-
7.1.2 Canada Bio-pharma Market Volume and Growth Rate
-
7.1.3 Mexico Bio-pharma Market Volume and Growth Rate
8. Europe Bio-pharma Landscape Analysis
-
8.1 Europe Bio-pharma Landscape Analysis by Major Types
-
8.2 Europe Bio-pharma Landscape Analysis by Major End-Users
-
8.3 Europe Bio-pharma Landscape Analysis by Top Countries
-
8.3.1 Germany Bio-pharma Market Volume and Growth Rate
-
8.3.2 UK Bio-pharma Market Volume and Growth Rate
-
8.3.3 France Bio-pharma Market Volume and Growth Rate
-
8.3.4 Italy Bio-pharma Market Volume and Growth Rate
-
8.3.5 Spain Bio-pharma Market Volume and Growth Rate
-
8.3.6 Belgium Bio-pharma Market Volume and Growth Rate
-
8.3.7 Poland Bio-pharma Market Volume and Growth Rate
-
8.3.8 Russia Bio-pharma Market Volume and Growth Rate
-
8.3.9 Turkey Bio-pharma Market Volume and Growth Rate
-
8.3.10 Netherlands Bio-pharma Market Volume and Growth Rate
-
8.3.11 Portugal Bio-pharma Market Volume and Growth Rate
-
8.3.12 Denmark Bio-pharma Market Volume and Growth Rate
-
8.3.13 Finland Bio-pharma Market Volume and Growth Rate
-
8.3.14 Iceland Bio-pharma Market Volume and Growth Rate
-
8.3.15 Norway Bio-pharma Market Volume and Growth Rate
-
8.3.16 Sweden Bio-pharma Market Volume and Growth Rate
-
8.4 Top 3 Players Profiles in Europe
9 Asia Pacific Bio-pharma Landscape Analysis
-
9.1 Asia Pacific Bio-pharma Landscape Analysis by Top Countries
-
9.1.1 China Bio-pharma Market Volume and Growth Rate
-
9.1.2 Japan Bio-pharma Market Volume and Growth Rate
-
9.1.3 Australia and New Zealand (ANZ) Bio-pharma Market Volume and Growth Rate
-
9.1.4 India Bio-pharma Market Volume and Growth Rate
-
9.1.5 ASEAN Bio-pharma Market Volume and Growth Rate
-
9.1.6 South Korea Bio-pharma Market Volume and Growth Rate
10 LAMEA Bio-pharma Landscape Analysis
-
10.1 LAMEA Bio-pharma Landscape Analysis by Top Countries
-
10.1.1 GCC Countries Bio-pharma Market Volume and Growth Rate
-
10.1.2 Brazil Bio-pharma Market Volume and Growth Rate
-
10.1.3 North Africa Bio-pharma Market Volume and Growth Rate
-
10.1.4 South Africa Bio-pharma Market Volume and Growth Rate
-
10.1.5 Argentina Bio-pharma Market Volume and Growth Rate
11 Major Players Profiles
-
11.1 AstraZeneca PLC
-
11.1.1 AstraZeneca PLC Company Profile and Recent Development
-
11.1.2 Market Performance
-
11.1.3 Product and Service Introduction
-
11.2 AbbVie
-
11.2.1 AbbVie Company Profile and Recent Development
-
11.2.2 Market Performance
-
11.2.3 Product and Service Introduction
-
11.3 Johnson & Johnson Services
-
11.3.1 Johnson & Johnson Services Company Profile and Recent Development
-
11.3.2 Market Performance
-
11.3.3 Product and Service Introduction
-
11.4 Pfizer
-
11.4.1 Pfizer Company Profile and Recent Development
-
11.4.2 Market Performance
-
11.4.3 Product and Service Introduction
-
11.5 Bristol-Myers Squibb Company
-
11.5.1 Bristol-Myers Squibb Company Company Profile and Recent Development
-
11.5.2 Market Performance
-
11.5.3 Product and Service Introduction
-
11.6 Abbott Laboratories
-
11.6.1 Abbott Laboratories Company Profile and Recent Development
-
11.6.2 Market Performance
-
11.6.3 Product and Service Introduction
-
11.7 Bayer AG
-
11.7.1 Bayer AG Company Profile and Recent Development
-
11.7.2 Market Performance
-
11.7.3 Product and Service Introduction
-
11.8 Novartis AG GlaxoSmithKline Plc
-
11.8.1 Novartis AG GlaxoSmithKline Plc Company Profile and Recent Development
-
11.8.2 Market Performance
-
11.8.3 Product and Service Introduction
-
11.9 Sanofi, Amgen
-
11.9.1 Sanofi, Amgen Company Profile and Recent Development
-
11.9.2 Market Performance
-
11.9.3 Product and Service Introduction
-
11.10 Biogen Idec
-
11.10.1 Biogen Idec Company Profile and Recent Development
-
11.10.2 Market Performance
-
11.10.3 Product and Service Introduction
-
11.11 Eli Lilly and Company
-
11.11.1 Eli Lilly and Company Company Profile and Recent Development
-
11.11.2 Market Performance
-
11.11.3 Product and Service Introduction
The List of Tables and Figures (Totals 115 Figures and 166 Tables)
-
Figure Product Picture
-
Figure Market Size and Growth Rate of Monoclonal Antibodies
-
Figure Market Size and Growth Rate of Recombinant Proteins
-
Figure Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF)
-
Figure Market Size and Growth Rate of Interferons
-
Figure Market Size and Growth Rate of Recombinant Human Insulin
-
Figure Market Size and Growth Rate of Erythropoietin
-
Figure Market Size and Growth Rate of Vaccines
-
Figure Market Size and Growth Rate of Growth Hormones
-
Figure Market Size and Growth Rate of Purified Proteins
-
Figure Market Size and Growth Rate of Others
-
Figure Market Size and Growth Rate of Metabolic Disorders
-
Figure Market Size and Growth Rate of Oncology
-
Figure Market Size and Growth Rate of Neurological Disorders
-
Figure Market Size and Growth Rate of Cardiovascular Diseases
-
Figure Market Size and Growth Rate of Inflammatory and Infectious Diseases
-
Figure Market Size and Growth Rate of Others
-
Figure North America Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure United States Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure Canada Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure Mexico Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure Europe Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure Germany Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure UK Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure France Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure Italy Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure Nordic Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure Spain Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure Belgium Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure Poland Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure Russia Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure Turkey Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure Asia-Pacific Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure China Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure Japan Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure Australia Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure India Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure ASEAN Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure South Korea Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure LAMEA Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure GCC Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure Brazil Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure North Africa Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure South Africa Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure Argentina Bio-pharma Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Bio-pharma Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Bio-pharma
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Bio-pharma by Different Types from 2014 to 2026
-
Table Consumption Share of Bio-pharma by Different Types from 2014 to 2026
-
Figure Market Size and Growth Rate of Monoclonal Antibodies
-
Figure Market Size and Growth Rate of Recombinant Proteins
-
Figure Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF)
-
Figure Market Size and Growth Rate of Interferons
-
Figure Market Size and Growth Rate of Recombinant Human Insulin
-
Figure Market Size and Growth Rate of Erythropoietin
-
Figure Market Size and Growth Rate of Vaccines
-
Figure Market Size and Growth Rate of Growth Hormones
-
Figure Market Size and Growth Rate of Purified Proteins
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Bio-pharma by Different End-Users from 2014 to 2026
-
Table Consumption Share of Bio-pharma by Different End-Users from 2014 to 2026
-
Figure Market Size and Growth Rate of Metabolic Disorders
-
Figure Market Size and Growth Rate of Oncology
-
Figure Market Size and Growth Rate of Neurological Disorders
-
Figure Market Size and Growth Rate of Cardiovascular Diseases
-
Figure Market Size and Growth Rate of Inflammatory and Infectious Diseases
-
Figure Market Size and Growth Rate of Others
-
Table Global Bio-pharma Production by Major Regions
-
Table Global Bio-pharma Production Share by Major Regions
-
Table Global Bio-pharma Consumption by Major Regions
-
Table Global Bio-pharma Consumption Share by Major Regions
-
Table North America Bio-pharma Production, Import, Consumption and Export Analysis
-
Table Europe Bio-pharma Production, Import, Consumption and Export Analysis
-
Table Asia Pacific Bio-pharma Production, Import, Consumption and Export Analysis
-
Table LAMEA Bio-pharma Production, Import, Consumption and Export Analysis
-
Table Top 5 Export Countries' Export Value Analysis in Bio-pharma Market from 2014 to 2019
-
Table Top 5 Export Countries' Export Volume Analysis in Bio-pharma Market from 2014 to 2019
-
Table Top 5 Import Countries' Import Value Analysis in Bio-pharma Market from 2014 to 2019
-
Table Top 5 Import Countries' Import Volume Analysis in Bio-pharma Market from 2014 to 2019
-
Figure Emerging Top 3 Export Countries Analysis
-
Figure Emerging Top 3 Import Countries Analysis
-
Table North America Bio-pharma Consumption by Major Countries from 2014 to 2026
-
Table North America Bio-pharma Consumption Share by Major Countries from 2014 to 2026
-
Figure North America Bio-pharma Consumption Share by Major Countries in 2014
-
Figure North America Bio-pharma Consumption Share by Major Countries in 2018
-
Figure North America Bio-pharma Consumption Share by Major Countries in 2026
-
Figure United States Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure Canada Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure Mexico Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Table Europe Bio-pharma Consumption by Types from 2014 to 2026
-
Table Europe Bio-pharma Consumption Share by Types from 2014 to 2026
-
Table Europe Bio-pharma Consumption by End-Users from 2014 to 2026
-
Table Europe Bio-pharma Consumption Share by End-Users from 2014 to 2026
-
Table Europe Bio-pharma Consumption by Major Countries from 2014 to 2026
-
Table Europe Bio-pharma Consumption Share by Major Countries from 2014 to 2026
-
Figure Germany Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure UK Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure France Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure Italy Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure Nordic Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure Spain Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure Belgium Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure Poland Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure Russia Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure Turkey Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure Netherlands Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure Portugal Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure Denmark Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure Finland Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure Iceland Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure Norway Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure Sweden Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Table Asia Pacific Bio-pharma Consumption by Major Countries from 2014 to 2026
-
Table Asia Pacific Bio-pharma Consumption Share by Major Countries from 2014 to 2026
-
Figure China Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure Japan Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure Australia Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure India Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure ASEAN Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure South Korea Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Table Latin America, Middle East & Africa Bio-pharma Consumption by Major Countries from 2014 to 2026
-
Table Latin America, Middle East & Africa Bio-pharma Consumption Share by Major Countries from 2014 to 2026
-
Figure GCC Countries Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure Brazil Countries Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure North Africa Countries Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure South Africa Countries Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Figure Argentina Countries Bio-pharma Market Volume and Growth Rate from 2014 to 2026
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca PLC
-
Figure Sales and Growth Rate Analysis of AstraZeneca PLC
-
Figure Revenue and Market Share Analysis of AstraZeneca PLC
-
Table Product and Service Introduction of AstraZeneca PLC
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
-
Figure Sales and Growth Rate Analysis of AbbVie
-
Figure Revenue and Market Share Analysis of AbbVie
-
Table Product and Service Introduction of AbbVie
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson Services
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson Services
-
Figure Revenue and Market Share Analysis of Johnson & Johnson Services
-
Table Product and Service Introduction of Johnson & Johnson Services
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company
-
Table Product and Service Introduction of Bristol-Myers Squibb Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories
-
Figure Sales and Growth Rate Analysis of Abbott Laboratories
-
Figure Revenue and Market Share Analysis of Abbott Laboratories
-
Table Product and Service Introduction of Abbott Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG
-
Figure Sales and Growth Rate Analysis of Bayer AG
-
Figure Revenue and Market Share Analysis of Bayer AG
-
Table Product and Service Introduction of Bayer AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG GlaxoSmithKline Plc
-
Figure Sales and Growth Rate Analysis of Novartis AG GlaxoSmithKline Plc
-
Figure Revenue and Market Share Analysis of Novartis AG GlaxoSmithKline Plc
-
Table Product and Service Introduction of Novartis AG GlaxoSmithKline Plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi, Amgen
-
Figure Sales and Growth Rate Analysis of Sanofi, Amgen
-
Figure Revenue and Market Share Analysis of Sanofi, Amgen
-
Table Product and Service Introduction of Sanofi, Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen Idec
-
Figure Sales and Growth Rate Analysis of Biogen Idec
-
Figure Revenue and Market Share Analysis of Biogen Idec
-
Table Product and Service Introduction of Biogen Idec
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company
-
Figure Sales and Growth Rate Analysis of Eli Lilly and Company
-
Figure Revenue and Market Share Analysis of Eli Lilly and Company
-
Table Product and Service Introduction of Eli Lilly and Company
-
